Active ingredientAnamorelinCat. No. P-A153-001CAS 249921-19-5Family · Pharmaceutical analytical standards
Anamorelin
An oral ghrelin receptor agonist, approved in Japan in 2021 for cancer cachexia, the severe loss of weight and muscle linked to non-small cell lung, gastric, pancreatic and colorectal cancers. This family brings together the active ingredient and other impurities.
Did you know?It mimics ghrelin, a hormone made mainly by the stomach that stimulates appetite: besides making you hungry, it triggers the release of growth hormone and raises IGF-1 levels.
Go to the active ingredient →Active ingredientAnamorelinCat. No. P-A153-001CAS 249921-19-5
ImpurityAnamorelin Impurity 1Cat. No. P-A153-002CAS 249921-30-0
ImpurityAnamorelin Impurity 2Cat. No. P-A153-003
Impurityent-AnamorelinCat. No. P-A153-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.